Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

AREA 23 on Hudson | An IPG Health CompanyAREA 23 on Hudson | An IPG Health Company
VS
Hikma PharmaceuticalsHikma Pharmaceuticals
AREA 23 on Hudson | An IPG Health Company

AREA 23 on Hudson | An IPG Health Company

N/A

Last Update: 16/01/2026

View Profile
752/1000Fair

AREA 23 on Hudson, an IPG Health Company, is a team of creative problem-solvers who don’t believe in a cookie-cutter approach to medical communications. Driven by a shared vision with our client partners, we innovate solutions to create lasting impact with HCPs. We do...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:73
Subsidiaries:32
12-month incidents
0
Known data breaches
0
Attack type number
0
Hikma Pharmaceuticals

Hikma Pharmaceuticals

1 New Burlington Place, London, W1S 2HR, GB

Last Update: 12/09/2026

View Profile
Between 750 and 799
http://www.hikma.com
768/1000Fair

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:10,252
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
AREA 23 on Hudson | An IPG Health Company

AREA 23 on Hudson | An IPG Health Company

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Hikma Pharmaceuticals

Hikma Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AREA 23 on Hudson | An IPG Health Company in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Hikma Pharmaceuticals in 2026.

Incidents

Incident History - AREA 23 on Hudson | An IPG Health Company (X = Date, Y = Severity)

AREA 23 on Hudson | An IPG Health Company cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)

Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
AREA 23 on Hudson | An IPG Health Company

AREA 23 on Hudson | An IPG Health Company

Incidents
No explicit notable incidents reported.
Hikma Pharmaceuticals

Hikma Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one has experienced at least one data breach ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one holds the most compliance certifications ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one has the most subsidiaries ?
Between AREA 23 on Hudson | An IPG Health Company company and Hikma Pharmaceuticals company, which one has the largest number of employees ?
Between AREA 23 on Hudson | An IPG Health Company and Hikma Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between AREA 23 on Hudson | An IPG Health Company and Hikma Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - AREA 23 on Hudson | An IPG Health Company or Hikma Pharmaceuticals ?
Which company is PCI DSS compliant - AREA 23 on Hudson | An IPG Health Company or Hikma Pharmaceuticals ?
Between AREA 23 on Hudson | An IPG Health Company and Hikma Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between AREA 23 on Hudson | An IPG Health Company and Hikma Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-111865
SUMMARY

A security flaw has been discovered in THU-MIG yoloe up to 40cd606cabdbe2b566d6f14a6b162c89206e9a1b. This affects the function eval of the file ultralytics/nn/autobackend.py of the component AutoBackend Model Loading. The manipulation of the argument imgsz/names/kpt_shape results in improper neutralization of directives in dynamically evaluated code. The attack requires a local approach. The exploit has been released to the public and may be used for attacks. This product does not use versioning. This is why information about affected and unaffected releases are unavailable. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 5.3)
CVSS2
Base Score: 4.3
Complexity: LOW
AV:L/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 1.9
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
1.8
CVE-2026-111934
SUMMARY

Coder before 2.34.7 contains an IP spoofing vulnerability in the ExtractRealIPAddress middleware that trusts the leftmost, client-supplied X-Forwarded-For value instead of the client IP appended by a reverse proxy. Attackers can send forged X-Forwarded-For values through appending proxies to bypass per-IP rate limits on login, one-time passcode, and password validation endpoints, enabling brute-force attacks, and to falsify IP addresses recorded in audit logs.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:L/A:N
CVSS4
Base Score: 6.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-111933
SUMMARY

Coder before 2.29.17, 2.30.0 before 2.32.7, 2.33.0 before 2.33.8, and 2.34.0 before 2.34.2 contains a user enumeration vulnerability because userpassword.Compare() substitutes a placeholder hash derived from the string "hunter2" when a stored password hash is empty. Unauthenticated attackers can submit logins with the password "hunter2" and distinguish HTTP 403 from 401 responses to enumerate valid accounts and reveal the authentication provider of SSO-only users.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.3
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-111932
SUMMARY

Coder before 2.29.17, 2.30.0 before 2.32.7, 2.33.0 before 2.33.8, and 2.34.0 before 2.34.2 contains a stored HTML injection vulnerability because the ApplicationName and LogoURL appearance settings are rendered into HTML output without sufficient escaping. Attackers with the Owner role can store HTML markup in these settings that renders in the Coder dashboard and in SMTP notification emails sent to other deployment users.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 3.4)
CVSS3
Base Score: 3.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:N/I:L/A:N
CVSS4
Base Score: 4.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
1.7
CVE-2026-111931
SUMMARY

Coder from 2.0.0 before 2.34.8 contains an open redirect vulnerability in handleAPIKeySmuggling that allows attackers to redirect users externally via unsanitized r.URL.Path values. Attackers can craft links on trusted workspace app subdomains with paths beginning with double slashes, which become scheme-relative redirects to attacker sites for phishing.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8